Avenue Therapeutics, Inc. SEC filings ATXI
Avenue Therapeutics, Inc. has 423 filings in SEC EDGAR's recent list, going back to Dec 30, 2015. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Feb 23, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 23, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Dec 31, 2025 | Dec 30, 2025 |
| EFFECT | Filing | Dec 16, 2025 | — |
| POS AM | Filing | Dec 15, 2025 | — |
| RW | Filing | Dec 15, 2025 | — |
| DEF 14A | Proxy statement | Dec 5, 2025 | Dec 30, 2025 |
| 8-K |
Current report
Other events
|
Nov 18, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Nov 12, 2025 | Nov 5, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 25-NSE | Delisting notice | Jul 18, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets
|
Apr 30, 2025 | Apr 24, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Listing notice
|
Mar 17, 2025 | Mar 17, 2025 |
| 8-K |
Current report
Other events
|
Mar 7, 2025 | Mar 7, 2025 |
| S-3 | Shelf registration | Dec 4, 2024 | — |
| 8-K |
Current report
Listing notice
|
Nov 29, 2024 | Nov 26, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 27, 2024 | Sep 23, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2024 | Aug 9, 2024 |
| S-8 | Employee stock plan registration | Jul 12, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 26, 2024 | Jun 24, 2024 |
| 8-K |
Current report
Other events
|
May 23, 2024 | May 21, 2024 |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Material agreement
|
May 13, 2024 | May 10, 2024 |
| EFFECT | Filing | May 10, 2024 | — |
| 424B3 | Prospectus | May 10, 2024 | — |
| 424B5 | Prospectus supplement | May 10, 2024 | — |
| CORRESP | Letter to the SEC | May 8, 2024 | — |
| UPLOAD | Letter from the SEC | May 8, 2024 | — |
| S-3 | Shelf registration | May 6, 2024 | — |
| DEFA14A | Additional proxy material | May 6, 2024 | — |
| DEF 14A | Proxy statement | May 6, 2024 | Jun 22, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
May 1, 2024 | May 1, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Apr 26, 2024 | Apr 25, 2024 |
| 8-K |
Current report
Listing notice
|
Mar 29, 2024 | Mar 26, 2024 |
| DEF 14C | Information statement | Mar 18, 2024 | Mar 18, 2024 |
| 10-K | Annual report | Mar 18, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2024 | Mar 18, 2024 |
| 8-K |
Current report
Other events
|
Mar 15, 2024 | Mar 11, 2024 |
| PRE 14C | Filing | Mar 8, 2024 | Mar 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Mar 8, 2024 | Mar 6, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 23, 2024 | Feb 20, 2024 |
| 424B3 | Prospectus | Feb 2, 2024 | — |
| EFFECT | Filing | Feb 1, 2024 | — |
| CORRESP | Letter to the SEC | Jan 30, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2024 | — |
| DEF 14C | Information statement | Jan 29, 2024 | Jan 29, 2024 |
| S-3 | Shelf registration | Jan 24, 2024 | — |
| PRE 14C | Filing | Jan 17, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jan 12, 2024 | Jan 9, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
|
Jan 8, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 24, 2023 | Nov 20, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2023 | Nov 13, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 2, 2023 | Oct 31, 2023 |
| 424B4 | Prospectus | Nov 2, 2023 | — |
| EFFECT | Filing | Oct 31, 2023 | — |
| CORRESP | Letter to the SEC | Oct 30, 2023 | — |
| CORRESP | Letter to the SEC | Oct 30, 2023 | — |
| CORRESP | Letter to the SEC | Oct 27, 2023 | — |
| CORRESP | Letter to the SEC | Oct 27, 2023 | — |
| CORRESP | Letter to the SEC | Oct 24, 2023 | — |
| CORRESP | Letter to the SEC | Oct 24, 2023 | — |
| S-1/A | Amended registration statement | Oct 24, 2023 | — |
| FWP | Free writing prospectus | Oct 5, 2023 | — |
| FWP | Free writing prospectus | Oct 4, 2023 | — |
| S-1/A | Amended registration statement | Sep 29, 2023 | — |
| 8-K |
Current report
Listing notice
|
Sep 28, 2023 | Sep 27, 2023 |
| 8-K |
Current report
Other events
|
Sep 27, 2023 | Sep 27, 2023 |
| UPLOAD | Letter from the SEC | Sep 21, 2023 | — |
| S-1 | Registration statement | Sep 18, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 8, 2023 | Sep 8, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Other events
|
Jul 21, 2023 | Jul 17, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 5, 2023 | Jun 29, 2023 |
| 424B3 | Prospectus | Jun 28, 2023 | — |
| EFFECT | Filing | Jun 27, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2023 | Jun 22, 2023 |
| CORRESP | Letter to the SEC | Jun 23, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 22, 2023 | — |
| S-3 | Shelf registration | Jun 16, 2023 | — |
| 8-K |
Current report
Listing notice
|
May 22, 2023 | May 19, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 12, 2023 | May 12, 2023 |
| 424B3 | Prospectus | May 4, 2023 | — |
| EFFECT | Filing | May 3, 2023 | — |
| CORRESP | Letter to the SEC | May 1, 2023 | — |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Other events
|
Apr 17, 2023 | Apr 17, 2023 |
| UPLOAD | Letter from the SEC | Apr 17, 2023 | — |
| S-1 | Registration statement | Apr 11, 2023 | — |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2023 | Mar 30, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 8, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Mar 2, 2023 | Feb 28, 2023 |
| D | Filing | Feb 14, 2023 | — |
| S-8 | Employee stock plan registration | Feb 10, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 10, 2023 | Feb 9, 2023 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Feb 3, 2023 | Jan 30, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Feb 1, 2023 | Jan 27, 2023 |
| 424B5 | Prospectus supplement | Jan 31, 2023 | — |
| 8-K |
Current report
Auditor change
|
Jan 25, 2023 | Jan 21, 2023 |
| DEFA14A | Additional proxy material | Jan 17, 2023 | — |
| DEFA14A | Additional proxy material | Jan 4, 2023 | — |
| DEFA14A | Additional proxy material | Nov 18, 2022 | — |
| DEF 14A | Proxy statement | Nov 18, 2022 | Dec 28, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| PRE 14A | Preliminary proxy statement | Nov 8, 2022 | Dec 28, 2022 |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 4, 2022 | Oct 31, 2022 |
| 8-K |
Current report
Other events
|
Oct 18, 2022 | Oct 18, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 12, 2022 | Oct 6, 2022 |
| 424B4 | Prospectus | Oct 11, 2022 | — |
| EFFECT | Filing | Oct 6, 2022 | — |
| FWP | Free writing prospectus | Oct 6, 2022 | — |
| S-1/A | Amended registration statement | Oct 6, 2022 | — |
| CORRESP | Letter to the SEC | Oct 5, 2022 | — |
| CORRESP | Letter to the SEC | Oct 5, 2022 | — |
| S-1/A | Amended registration statement | Oct 5, 2022 | — |
| 8-K |
Current report
Listing notice
|
Sep 30, 2022 | Sep 29, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Sep 22, 2022 | Sep 22, 2022 |
| UPLOAD | Letter from the SEC | Sep 2, 2022 | — |
| S-1 | Registration statement | Aug 31, 2022 | — |
| 8-K |
Current report
Other events
|
Aug 31, 2022 | Aug 31, 2022 |
| DEF 14C | Information statement | Aug 22, 2022 | Aug 22, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Listing notice
|
Aug 12, 2022 | Aug 9, 2022 |
| PRE 14C | Filing | Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 3, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jul 29, 2022 | Jul 25, 2022 |
| 8-K |
Current report
Listing notice
|
May 25, 2022 | May 24, 2022 |
| 8-K |
Current report
Material agreement, Listing notice, Officer or director change
|
May 16, 2022 | May 11, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Officer or director change
|
May 13, 2022 | May 11, 2022 |
| 8-K |
Current report
Other events
|
Apr 5, 2022 | Apr 1, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 30, 2022 | Mar 28, 2022 |
| 10-K | Annual report | Mar 25, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Other events
|
Mar 21, 2022 | Mar 18, 2022 |
| 8-K |
Current report
Listing notice, Other events
|
Mar 8, 2022 | Mar 2, 2022 |
| 8-K |
Current report
Other events
|
Feb 16, 2022 | Feb 15, 2022 |
| 8-K |
Current report
Listing notice
|
Feb 11, 2022 | Feb 8, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 7, 2022 | Jan 5, 2022 |
| S-8 | Employee stock plan registration | Dec 17, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
Dec 16, 2021 | Dec 16, 2021 |
| 8-K |
Current report
Material agreement
|
Dec 13, 2021 | Dec 12, 2021 |
| 424B5 | Prospectus supplement | Dec 13, 2021 | — |
| EFFECT | Filing | Dec 10, 2021 | — |
| 424B5 | Prospectus supplement | Dec 10, 2021 | — |
| CORRESP | Letter to the SEC | Dec 9, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 8, 2021 | — |
| S-3 | Shelf registration | Dec 7, 2021 | — |
| DEF 14A | Proxy statement | Nov 23, 2021 | Dec 16, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 424B5 | Prospectus supplement | Nov 10, 2021 | — |
| 8-K |
Current report
Material agreement
|
Nov 10, 2021 | Nov 9, 2021 |
| 424B5 | Prospectus supplement | Nov 9, 2021 | — |
| 8-K |
Current report
Agreement ended
|
Nov 4, 2021 | Nov 1, 2021 |
| 8-K |
Current report
Other events
|
Oct 25, 2021 | Oct 21, 2021 |
| EFFECT | Filing | Oct 1, 2021 | — |
| CORRESP | Letter to the SEC | Oct 1, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2021 | — |
| S-3 | Shelf registration | Sep 28, 2021 | — |
| 8-K |
Current report
Other events
|
Sep 21, 2021 | Sep 17, 2021 |
| 8-K |
Current report
Listing notice
|
Sep 3, 2021 | Sep 2, 2021 |
| 8-K |
Current report
Other events
|
Sep 1, 2021 | Aug 31, 2021 |
| 8-K |
Current report
Other events
|
Aug 27, 2021 | Aug 26, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Other events
|
Jul 29, 2021 | Jul 27, 2021 |
| 8-K |
Current report
Other events
|
Jul 15, 2021 | Jul 14, 2021 |
| 8-K |
Current report
Other events
|
Jun 14, 2021 | Jun 11, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Other events
|
May 3, 2021 | May 1, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 5, 2021 | Apr 1, 2021 |
| 10-K | Annual report | Mar 31, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Other events
|
Mar 1, 2021 | Feb 26, 2021 |
| 8-K |
Current report
Other events
|
Feb 16, 2021 | Feb 12, 2021 |
| 8-K |
Current report
Listing notice
|
Jan 8, 2021 | Jan 5, 2021 |
| 8-K |
Current report
Other events
|
Dec 17, 2020 | Dec 15, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 4, 2020 | Dec 1, 2020 |
| 10-Q | Quarterly report | Nov 4, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Other events
|
Oct 13, 2020 | Oct 12, 2020 |
| 10-Q | Quarterly report | Aug 14, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2020 | Aug 14, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2020 | Jun 16, 2020 |
| DEFA14A | Additional proxy material | May 29, 2020 | — |
| 10-Q | Quarterly report | May 11, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 11, 2020 | May 11, 2020 |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 16, 2020 |
| 8-K |
Current report
Other events
|
Apr 23, 2020 | Apr 23, 2020 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ATXI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bay Harbor Islands, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1644963
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.